Skip to main content
. Author manuscript; available in PMC: 2020 Jun 9.
Published in final edited form as: Nature. 2019 Dec 9;577(7789):244–248. doi: 10.1038/s41586-019-1786-y

Extended Data Figure 2: Phage ΦKZ resists P. aeruginosa Type I-C and Type I-F CRISPR-Cas immunity.

Extended Data Figure 2:

a, Strain PAO1 was engineered to express the I-C cas genes and distinct crRNAs targeting phage JBD30 and phage ΦKZ, and plaque assays were conducted as in Fig. 1a. b, Strain PAO1 was engineered to express the I-F cas genes and distinct crRNAs targeting phage JBD30 and phage ΦKZ, and plaque assays were conducted as in Fig. 1a. All plaque assays replicated ≥ 2 times with similar results.